Lista de obras -

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

artículo científico publicado en 2012

Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival

artículo científico publicado en 2013

Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer.

artículo científico publicado en 2012

Developing imaging strategies for castration resistant prostate cancer

artículo científico publicado en 2011

Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 29 September 2020

Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.

artículo científico publicado en 2016

First-in-Human Trial of Epichaperome-Targeted Positron Emission Tomography in Cancer Patients

scientific article published on 04 May 2020

Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody

scientific article published on 03 May 2019

Immunomodulatory Activity of a Colony-Stimulating Factor-1 Receptor Inhibitor in Patients With Advanced Refractory Breast or Prostate Cancer: A Phase 1 Study

artículo científico publicado en 2020

Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials

scientific article published on 29 April 2019

Molecular imaging of prostate cancer.

artículo científico publicado en 2012

Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up

artículo científico publicado en 2015

Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients

artículo científico publicado en 2019

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer

artículo científico publicado en 2013

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer

artículo científico publicado en 2017

Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma.

artículo científico publicado en 2012

Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT

artículo científico publicado en 2011

Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography

artículo científico publicado en 2014

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer

artículo científico publicado en 2010

Response

artículo científico publicado en 2015

The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature

artículo científico publicado en 2017

Lista de obras de

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival

Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer.

Developing imaging strategies for castration resistant prostate cancer

Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer

Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.

First-in-Human Trial of Epichaperome-Targeted Positron Emission Tomography in Cancer Patients

Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody

Immunomodulatory Activity of a Colony-Stimulating Factor-1 Receptor Inhibitor in Patients With Advanced Refractory Breast or Prostate Cancer: A Phase 1 Study

Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials

Molecular imaging of prostate cancer.

Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up

Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer

Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma.

Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT

Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer

Response

The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature